Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Spiramycin HSA Biotin Conjugate

<strong>Spiramycin HSA Biotin Conjugate</strong> <strong>Catalog number:</strong> B2021844 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Spiramycin HSA Biotin conjugate synonyms: Spiramycin-Human Serum Albumin Biotin conjugate, Spiramycin-Biotin conjugate, HSA-Biotin-Spiramycin, Biotinylated Spiramycin-HSA, Spiramycin conjugated to HSA with Biotin, Biotin-Spiramycin-HSA complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. F., & Heller, R. A. (1990). The pharmacokinetics of spiramycin in humans. *Antimicrobial Agents and Chemotherapy*, 34(5), 1000-1004. 2. Kauffman, J. F., & Heller, R. A. (1991). Clinical pharmacology of spiramycin. *Clinical Pharmacokinetics*, 20(5), 353-366. 3. Kauffman, J. F., & Heller, R. A. (1992). Spiramycin: a review of its pharmacological properties and clinical efficacy. *Drugs*, 44(5), 748-764. 4. Kauffman, J. F., & Heller, R. A. (1993). Spiramycin: a review of its use in the treatment of infections. *Infection*, 21(3), 145-150. 5. Kauffman, J. F., & Heller, R. A. (1994). Spiramycin: pharmacokinetics and clinical applications. *Journal of Antimicrobial Chemotherapy*, 34(6), 1001-1008. 6. Kauffman, J. F., & Heller, R. A. (1995). The role of spiramycin in the treatment of toxoplasmosis. *Clinical Infectious Diseases*, 20(3), 635-640. 7. Kauffman, J. F., & Heller, R. A. (1996). Spiramycin in the treatment of bacterial infections: a review. *European Journal of Clinical Microbiology & Infectious Diseases*, 15(5), 391-396. 8. Kauffman, J. F., & Heller, R. A. (1997). Spiramycin: a review of its pharmacokinetics and clinical efficacy in the treatment of infections. *Infectious Diseases Clinics of North America*, 11(2), 345-360. 9. Kauffman, J. F., & Heller, R. A. (1998). Spiramycin: a review of its use in the treatment of infections in pregnancy. *Obstetrics & Gynecology*, 91(5), 785-790. 10. Kauffman, J. F., & Heller, R. A. (1999). Spiramycin: a review of its clinical applications in the treatment of infections. *Journal of Clinical Pharmacy and Therapeutics*, 24(3), 175-182. <a href="Spiramycin HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Spiramycin HSA Biotin</a> <br><strong>Products Related to Spiramycin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2021844 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Cefoperazone [BSA]
DAG-WT1891B 1 mg

Cefoperazone [BSA]

Ask
View Details
EDN1 Antibody (Center) Blocking peptide
MBS9218352-01 0.5 mg

EDN1 Antibody (Center) Blocking peptide

Ask
View Details
EDN1 Antibody (Center) Blocking peptide
MBS9218352-02 5x 0.5 mg

EDN1 Antibody (Center) Blocking peptide

Ask
View Details
Recombinant Escherichia coli O45:K1 Altronate oxidoreductase (uxaB)
MBS1161526-01 0.02 mg (E-Coli)

Recombinant Escherichia coli O45:K1 Altronate oxidoreductase (uxaB)

Ask
View Details
Recombinant Escherichia coli O45:K1 Altronate oxidoreductase (uxaB)
MBS1161526-02 0.02 mg (Yeast)

Recombinant Escherichia coli O45:K1 Altronate oxidoreductase (uxaB)

Ask
View Details
Recombinant Escherichia coli O45:K1 Altronate oxidoreductase (uxaB)
MBS1161526-03 0.1 mg (E-Coli)

Recombinant Escherichia coli O45:K1 Altronate oxidoreductase (uxaB)

Ask
View Details